So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Thang đo chất lượng cuộc sống liên quan đến sức khỏe GERD× | Chỉ số Triệu chứng Cốt lõi của Bệnh Dạ dày Tê liệt (GCSI)× | |
|---|---|---|
| Lĩnh vực | Tiêu hóa học | Tiêu hóa học |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 1996 | 2003 |
| Người khởi xướng≠ | Velanovich, V., Zhang, Y., Hollis, J. B., et al. | Revicki, D. A., Rentz, A. M., Dubois, D., et al. |
| Loại | Self-report | Self-report |
| Công trình gốc≠ | Velanovich, V., Zhang, Y., Hollis, J. B., Feldman, M. I., Sampliner, R., Guan, W., & Escamilla, C. (1996). Presenting symptoms and outcome measures in reflux esophagitis. Digestive Diseases and Sciences, 41(10), 1865–1873. link ↗ | Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150. link ↗ |
| Tên gọi khác≠ | GERD-HRQL, GERD-HRQoL | GCSI |
| Liên quan | 4 | 4 |
| Tóm tắt≠ | The GERD Health-Related Quality of Life Scale (GERD-HRQL) is a concise, validated patient-reported outcome measure for assessing the symptomatic and functional impact of gastroesophageal reflux disease (GERD). Developed by Velanovich and colleagues in 1996, the 9-item GERD-HRQL measures heartburn frequency and severity, regurgitation, and impact on sleep and medication use. The scale is highly responsive to proton pump inhibitor (PPI) therapy and is widely used in GERD trials and clinical practice. | The Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response. |
| ScholarGateBộ dữ liệu ↗ |
|
|